RecruitingPhase 1NCT05504837
A Study Assessing KB407 for the Treatment of Cystic Fibrosis
Studying Congenital pulmonary airway malformation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Krystal Biotech, Inc.
- Intervention
- KB407 (Nebulization)(biological)
- Enrollment
- 12 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2026
Study locations (5)
- University of Florida, Gainesville, Gainesville, Florida, United States
- The Cystic Fibrosis Institute, Northfield, Illinois, United States
- New York Medical College/ Boston Children's Health Physicians, Hawthorne, New York, United States
- Northwell Health Physicians, New York, New York, United States
- Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05504837 on ClinicalTrials.govOther trials for Congenital pulmonary airway malformation
Additional recruiting or active studies for the same condition.
- RECRUITINGEARLY PHASE1NCT07569419Proof of Principle Study for an Efficacy Trial of Linaclotide for Cystic FibrosisUniversity of Nottingham
- RECRUITINGNANCT06132048A Usability Validation of the MuCopilot Mobile Application, a Digital Tool for the Unsupervised Objective Assessment of Cystic FibrosisAd scientiam
- ACTIVE NOT RECRUITINGNCT06371261Pathogenicity of Species of the Achromobacter Genus in Patients From Reunion Island With Cystic FibrosisCentre Hospitalier Universitaire de la Réunion
- RECRUITINGNANCT06302985Atomized Inhalation ICG for Treatment of Congenital Lung MalformationsJiexiong Feng
- ACTIVE NOT RECRUITINGNCT07568119Feasibility and Acceptance of SonoHeal for Airway Clearance and Preliminary Comparison With the Standard of CareCognita Labs LLC
- RECRUITINGNANCT05701514The COllaborative Neonatal Network for the First CPAM TrialErasmus Medical Center
- ACTIVE NOT RECRUITINGPHASE3NCT05444257A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination TherapyVertex Pharmaceuticals Incorporated
- RECRUITINGNCT02270476Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Following Newborn ScreeningHeidelberg University
See all trials for Congenital pulmonary airway malformation →